Iran Conflict Pushes CE Price Target to $81

• Celanese (CE) generated $773M in free cash flow in 2025, up 45.57% year over year, and targets $650-750M for 2026, while its Acetyl Chain segment posted $940M in Q4 2025 revenue and stands to benefit from acetic acid supply compression driven by Middle East disruptions.

• Citi raised Celanese’s price target to $81 from $75 based on commodity chemical repricing expectations following potential Strait of Hormuz closure by Iran, which would compress global acetic acid supply and restore margin for integrated producers.

• The analyst who called NVIDIA in 2010 just named his top 10 AI stocks. Get them here FREE.

Celanese Corporation (NYSE:CE) has staged a sharp recovery in 2026, gaining 35.77% year-to-date. The stock’s one-week gain stands at 9.15%, though shares are up just 8.43% over the past year and down more than 66% from their five-year high in January 2022.

Wall Street’s consensus price target sits at $63.12, reflecting a cautious analyst community. Now Citi has broken from that pack, raising its price target on CE to $81 from $75 with a Buy rating. But can CE realistically reach $81 by the end of 2026?

READ: The analyst who called NVIDIA in 2010 just named his top 10 AI stocks

Citi’s upgrade centers on a significant upward revision to commodity chemical forecasts driven by the Iran conflict and the closure of the Strait of Hormuz, which is disrupting global chemical capacity and shipments. The geopolitical pressure is real: prediction markets are pricing a 99.95% probability of Iran closing the Strait by year-end 2026, backed by over $51 million in total trading volume. WTI crude has surged to $95.41 per barrel as of March 12, up more than $23 in a single week, validating the supply shock thesis that underpins Citi’s revised chemical price deck.

1. Commodity chemical repricing: Celanese’s Acetyl Chain segment, which posted $940 million in Q4 2025 revenue, down 15% year over year, is most exposed to feedstock dynamics. A sustained oil and energy price spike compresses global acetic acid supply, potentially restoring pricing power and margin for integrated producers like Celanese.

2. Free cash flow discipline: Despite a difficult 2025, Celanese generated $773 million in free cash flow, up 45.57% year over year, and is targeting $650 to $750 million in 2026. That cash engine supports ongoing deleveraging and positions the company to compound value through the cycle.

3. Balance sheet stabilization: The completed Micromax divestiture for approximately $500 million, combined with a new $1.75 billion revolving credit facility extending through 2030, reduces near-term refinancing risk and gives management room to execute on recovery.

Key conditions include: a sustained commodity chemical price recovery driven by Hormuz supply disruption; continued execution on the $120 million-plus cost reduction program; and stabilization in automotive and industrial end-market demand, which has weighed on results throughout 2025.

The primary risk is Celanese’s $11.3 billion net debt load, which leaves little margin for error if demand recovery stalls or commodity prices reverse. That said, CEO Scott Richardson’s focus on cash generation and deleveraging, combined with a genuine geopolitical supply catalyst, gives Citi’s $81 target a credible fundamental foundation.

Wall Street is pouring billions into AI, but most investors are buying the wrong stocks. The analyst who first identified NVIDIA as a buy back in 2010 — before its 28,000% run — has just pinpointed 10 new AI companies he believes could deliver outsized returns from here. One dominates a $100 billion equipment market. Another is solving the single biggest bottleneck holding back AI data centers. A third is a pure-play on an optical networking market set to quadruple. Most investors haven’t heard of half these names. Get the free list of all 10 stocks here.